FlashZero Corp
CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. … Read more
FlashZero Corp (FZRO) - Net Assets
Latest net assets as of June 2024: $499.42 Million USD
Based on the latest financial reports, FlashZero Corp (FZRO) has net assets worth $499.42 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($499.42 Million) and total liabilities ($613.00). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $499.42 Million |
| % of Total Assets | 100.0% |
| Annual Growth Rate | 29.39% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FlashZero Corp - Net Assets Trend (2005–2023)
This chart illustrates how FlashZero Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FlashZero Corp (2005–2023)
The table below shows the annual net assets of FlashZero Corp from 2005 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $499.41 Million | +1595498.34% |
| 2022-12-31 | $-31.30K | +98.41% |
| 2014-12-31 | $-1.97 Million | -2.27% |
| 2013-12-31 | $-1.93 Million | -0.80% |
| 2012-12-31 | $-1.91 Million | -5.43% |
| 2009-12-31 | $-1.81 Million | -17.47% |
| 2008-12-31 | $-1.54 Million | +47.11% |
| 2007-12-31 | $-2.92 Million | -56.93% |
| 2006-12-31 | $-1.86 Million | -138.48% |
| 2005-12-31 | $4.84 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to FlashZero Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 296335500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.11K | 0.00% |
| Other Comprehensive Income | $-1.11K | 0.00% |
| Other Components | $504.18 Million | 100.95% |
| Total Equity | $499.41 Million | 100.00% |
FlashZero Corp Competitors by Market Cap
The table below lists competitors of FlashZero Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sagiang Import&Export Corporation
VN:SGC
|
$28.46K |
|
CONSTANCE LA GAIETE COMPANY LTD
SEM:CSE
|
$28.46K |
|
Fision Corp
PINK:FSSN
|
$28.47K |
|
SRAX Inc
NASDAQ:SRAX
|
$28.47K |
|
GemLife Communities Group
AU:GLF
|
$28.42K |
|
DataSolution Inc.
KO:263800
|
$28.41K |
|
KUBOTEK
MU:KBK
|
$28.41K |
|
KSFinance Group JSC
VN:KSF
|
$28.39K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FlashZero Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -31,302 to 499,407,541, a change of 499,438,843.
- Net loss of 21,997 reduced equity.
- Other comprehensive income increased equity by 243.
- Other factors increased equity by 499,460,597.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-22.00K | -0.0% |
| Other Comprehensive Income | $243.00 | +0.0% |
| Other Changes | $499.46 Million | +100.01% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares FlashZero Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.64x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $-2920340.00 | $2.90 | x |
| 2008-12-31 | $-1544672.00 | $2.90 | x |
| 2009-12-31 | $-1814465.00 | $2.90 | x |
| 2022-12-31 | $-0.12 | $2.90 | x |
| 2023-12-31 | $4.51 | $2.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently FlashZero Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -17.45%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.00x
- Recent ROE (-0.00%) is above the historical average (-2.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-333.34K |
| 2005 | -26.01% | 0.00% | 0.00x | 1.20x | $-1.74 Million |
| 2006 | 0.00% | -124227.89% | 0.02x | 0.00x | $-900.90K |
| 2007 | 0.00% | -152217.75% | 0.02x | 0.00x | $-873.95K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-247.16K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-88.35K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $154.35K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $177.44K |
| 2014 | 0.00% | -1493.22% | 0.05x | 0.00x | $154.05K |
| 2022 | 0.00% | 20.41% | 1.99x | 0.00x | $8.34K |
| 2023 | 0.00% | -17.45% | 0.00x | 1.00x | $-49.96 Million |
Industry Comparison
This section compares FlashZero Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FlashZero Corp (FZRO) | $499.42 Million | 0.00% | 0.00x | $28.43K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |